Biolargo, Inc.
BLGO· OTC
Filed Nov 14, 2012 · 10-Q · 45 days after period end · 0001437749-12-011730
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Revenue | $10.49K | $120.53K | $42.84K |
| Net Income | -$915.67K | -$711.67K | -$1.17M |
| EPS Diluted | -$0.01 | -$0.01 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biolargo, Inc. · CIK 880242 · Engraved from SEC EDGAR
ended Sep 30, 2012 · filed Nov 14, 2012 · 45 d after period end